Compugen (CGEN) Long-Term Investments (2009 - 2015)
Compugen recorded quarterly Long-Term Investments of $2.1 million in Q4 2013, up 23.21% quarter-over-quarter from $1.7 million in Q4 2012, and up 23.21% year-over-year from $1.7 million in Q4 2012.
Compugen's Long-Term Investments history runs 4 years deep, the most recent figure standing at $2.1 million for Q4 2013.
- In Q4 2013, Long-Term Investments rose 23.21% year-over-year to $2.1 million; the TTM figure through Dec 2013 stood at $2.1 million (up 23.21% YoY), while the FY2013 annual figure was $2.1 million, up 23.21% from the prior year.
- Long-Term Investments came in at $2.1 million for Q4 2013 at Compugen, up from $1.7 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $7.8 million in Q4 2010 to a low of $1.7 million in Q4 2012.
- A 4-year average of $4.3 million and a median of $3.9 million in 2011 frame the typical range for Long-Term Investments.
- Across the five-year window, Long-Term Investments plunged 69.0% in 2012 and rose 23.21% in 2013, its largest moves.
- Compugen's Long-Term Investments stood at $7.8 million in 2010, then fell by 28.53% to $5.6 million in 2011, then slumped by 69.0% to $1.7 million in 2012, then grew by 23.21% to $2.1 million in 2013.
- According to Business Quant data, Long-Term Investments over the past three periods registered $2.1 million, $1.7 million, and $5.6 million for Q4 2013, Q4 2012, and Q4 2011 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 505,194.89 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 5.75 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 9.79 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 22.17 Mn |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 15.01 Mn |
| Mar 31, 2015 | 2.01 Mn |
| Dec 31, 2014 | 35.03 Mn |
| Sep 30, 2014 | 2.08 Mn |
| Jun 30, 2014 | 2.26 Mn |
| Mar 31, 2014 | 2.16 Mn |
| Dec 31, 2013 | 2.13 Mn |
| Sep 30, 2013 | 2.01 Mn |
| Jun 30, 2013 | 1.92 Mn |
| Mar 31, 2013 | 1.88 Mn |
| Dec 31, 2012 | 1.73 Mn |
| Sep 30, 2012 | 5.89 Mn |
| Jun 30, 2012 | 6.26 Mn |
| Mar 31, 2012 | 6.27 Mn |
| Dec 31, 2011 | 5.58 Mn |
| Sep 30, 2011 | 5.69 Mn |
| Jun 30, 2011 | 6.57 Mn |
| Mar 31, 2011 | 7.40 Mn |
| Dec 31, 2010 | 7.80 Mn |
| Sep 30, 2010 | 6.76 Mn |
| Jun 30, 2010 | 5.06 Mn |
| Mar 31, 2010 | 7.10 Mn |
| Dec 31, 2009 | 5.14 Mn |
| Sep 30, 2009 | 1.20 Mn |
| Jun 30, 2009 | 1.10 Mn |
| Mar 31, 2009 | 1.28 Mn |